Neuroform Ez 3
Device Stent
PDI 04546540697738
General payments
$239,622
Research payments
$56,610
Through program year 2025, $239,622 in general payments and $56,610 in research payments were reported against Neuroform Ez 3 (Stent).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $36,447 | 37 |
| 2025 | Research | $1,538 | 1 |
| 2024 | General | $45,311 | 28 |
| 2024 | Research | $7,994 | 5 |
| 2023 | General | $14,060 | 103 |
| 2023 | Research | $2,498 | 2 |
| 2022 | General | $45,393 | 45 |
| 2022 | Research | $7,885 | 5 |
| 2021 | General | $98,410 | 94 |
| 2021 | Research | $36,696 | 12 |
Breakdown
The top 5 of 34 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 18 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
307 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.